Type your tag names separated by a space and hit enter

Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis

Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis ID - 450864 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -